A facilitated case-based discussion about the complexities of managing problematic polypharmacy and deprescribing in patients on medicines with anticholinergic properties.
This is a follow on from the polypharmacy webinar series, which lays the foundations of some of the deprescribing tools available and features a generalist case study.
Why it’s important
The National Overprescribing review highlighted that 10% of medicines prescribed in primary care may be inappropriate and those taking 10 or more medicines are 300 times more likely to have a drug related hospital admission, highlighting the importance of deprescribing.
Structured medication reviews (SMRs) improve medication adherence, reduce unnecessary prescriptions, and optimise patient outcomes. By reviewing patient experience, symptoms, and medication use, healthcare professionals can minimise risk of harm, limit side effects, and prevent poor health outcomes. This approach ensures that treatments remain appropriate and effective for better management and enhanced quality of life.
What will be covered
- Case-based discussion about undertaking an SMR in a patient on medicines with anticholinergic properties
- Insight into a person-centred approach to deprescribing and optimising medicines outcomes for patients with problematic polypharmacy
- Discussion about the challenges that professionals commonly encounter in relation to considering deprescribing for patients taking medicines with anticholinergic properties
- If there is time, we will answer questions from the audience, with a focus on those relating to the case study
Speakers
A range of speakers from SPS and other organisations will help run this event.
Non-SPS speakers
Ðula Alićehajić-Bečić
Consultant Pharmacist: Frailty; Wrightington, Wigan and Leigh NHS Foundation Trust; and Co-chair of the British Geriatrics Society Pharmacy Group
Heather Smith
Consultant Pharmacist: Older People; NHS West Yorkshire Integrated Care Board
SPS speakers
Learn more about our SPS speakers below.